Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samia Mora

Showing results (141-150 of 260) with videos related to

Pageof 26
Sort By:
JAMA Cardiology|January 20, 2021
Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in WomenSagar B Dugani, M Vinayaga Moorthy, Chunying Li, et al.
JAMA Cardiology|September 18, 2024
Tailoring Risk Prediction Models to Local PopulationsAniket N Zinzuwadia, Olga Mineeva, Chunying Li, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Mediterranean Diet Social Network Impact along 11 Years in the Major US Media Outlets: Thematic and Quantitative Analysis Using TwitterMiguel Angel Alvarez-Mon, Cesar I Fernandez-Lazaro, Maria Llavero-Valero, et al.
Journal of the American Heart Association|June 3, 2018
Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification TherapyMarjorie Boyer, Valérie Lévesque, Paul Poirier, et al.
Contemporary Clinical Trials|October 12, 2020
The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized designRui Wang, Victor DeGruttola, Quanhong Lei, et al.
Clinical Chemistry|February 9, 2017
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in WomenPatrick R Lawler, Akintunde O Akinkuolie, Paul M Ridker, et al.
Circulation|April 29, 2017
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)Amit V Khera, Olga V Demler, Steven J Adelman, et al.
Clinical Chemistry|November 4, 2022
Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart DiseaseKarol M Pencina, Michael J Pencina, Patrick R Lawler, et al.
BMJ Open|February 14, 2019
Risk factors associated with premature myocardial infarction: a systematic review protocolSagar B Dugani, Ana Patricia Ayala Melendez, Roger Reka, et al.
International Journal of Endocrinology|November 27, 2018
Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical PracticeSaleh Aldasouqi, Samia Mora, Gaurav Bhalla, et al.
Pageof 26

Showing results (141-150 of 260) with videos related to

Sort By:
Pageof 26
JAMA Cardiology|January 20, 2021
Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in WomenSagar B Dugani, M Vinayaga Moorthy, Chunying Li, et al.
JAMA Cardiology|September 18, 2024
Tailoring Risk Prediction Models to Local PopulationsAniket N Zinzuwadia, Olga Mineeva, Chunying Li, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Mediterranean Diet Social Network Impact along 11 Years in the Major US Media Outlets: Thematic and Quantitative Analysis Using TwitterMiguel Angel Alvarez-Mon, Cesar I Fernandez-Lazaro, Maria Llavero-Valero, et al.
Journal of the American Heart Association|June 3, 2018
Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification TherapyMarjorie Boyer, Valérie Lévesque, Paul Poirier, et al.
Contemporary Clinical Trials|October 12, 2020
The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized designRui Wang, Victor DeGruttola, Quanhong Lei, et al.
Clinical Chemistry|February 9, 2017
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in WomenPatrick R Lawler, Akintunde O Akinkuolie, Paul M Ridker, et al.
Circulation|April 29, 2017
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)Amit V Khera, Olga V Demler, Steven J Adelman, et al.
Clinical Chemistry|November 4, 2022
Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart DiseaseKarol M Pencina, Michael J Pencina, Patrick R Lawler, et al.
BMJ Open|February 14, 2019
Risk factors associated with premature myocardial infarction: a systematic review protocolSagar B Dugani, Ana Patricia Ayala Melendez, Roger Reka, et al.
International Journal of Endocrinology|November 27, 2018
Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical PracticeSaleh Aldasouqi, Samia Mora, Gaurav Bhalla, et al.
Pageof 26